Anti-HIV effects of HIV vectors

Virology

Volumn 243, Issue 2, 1998, Pages 268-274

  Corbeau, Pierre ^a,b,c,d   Wong Staal, Flossie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIV MONTPELLIER   (France)

^c INSERM   (France)

^d HÔPITAL SAINT ELOI   (France)

Author keywords

Gene delivery system; Intracellular immunization; Retroviral vector

Indexed keywords

CD4 ANTIGEN; VIRUS RNA; VIRUS VECTOR;

ARTICLE; GENE TARGETING; GENE THERAPY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS INFECTION; VIRUS INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032502646     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9089     Document Type: Article

References (31)

1. Aldovini A., Young R. A. Mutations of RNA and proteins sequences involved in Human Immunodeficiency Virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1990;1920-1926.
2. +. Hum. Gene Ther. 5:1994;193-201.
3. Clavel F., Orenstein J. A mutant of Human immunodeficiency Virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 64:1990;5230-5234.
4. Clever J., Sassetti C., Parslow T. G. RNA secondary stucture and binding sites for gag gene products in the 5′ packaging signal of Human Immunodeficiency Virus type 1. J. Virol. 69:1995;2101-2109.
5. Clever J. L., Wong M. L., Parslow T. G. Requirements for kissing-loop-mediated dimerization of Human Immunodeficiency Virus RNA. J. Virol. 70:1996;5902-5908.
6. Corbeau P., Kraus G., Wong-Staal F. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA. 93:1996;14070-14075.
7. Corbeau P., Kraus G., Wong-Staal F. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system. Gene Ther. 1997.
8. Darlix J.-L., Gabus C., Nugeyre M. T., Clavel F., Barre-Sinoussi F. Cistrans. J. Mol. Biol. 216:1990;689-699.
9. Dropulic B., Jeang K.-T. Gene therapy for HIV infection: Genetic antiviral strategies and targets for intervention. Hum. Gene. Ther. 5:1994;927-940.
10. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS. 6:1992;347-363.
11. Graham G. J., Maio J. J. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc. Natl. Acad. Sci. USA. 87:1990;5817-5821.
12. Hayashi T., Shioda T., Iwakura Y., Shibuta H. RNA packaging signal of Human Immunodeficiency Virus type 1. Virology. 188:1992;590-599.
13. Hope T. J., Huang X., McDonald D., Parslow T. G. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: Mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad.Sci. USA. 87:1990;7787-7791.
14. Knight D. M., Flomerfelt F. A. G. Expression of the art/trs protein of HIV and study of its role in viral envelope synthesisi. Science. 236:1987;837-840.
15. Lee S.-W., Gallardo H. F., Gilboa E., Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent rev response element decoy consisting of the 13-nucleotide minimal rev-binding domain. J. Virol. 68:1994;8254-8264.
16. Lever A., Gottlinger H., Haseltine W., Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:1989;4085-4087.
17. Lisziewicz J., Sun D., Smythe J., Lusso P., Lori F., Louie A., Markham P., Rossi J., Reitz M., Gallo R. C. Inhibition of human immunodeficency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. Acad. Sci. USA. 90:1993;8000-8004.
18. Luznik L., Marton M. E., Kraus G., Zang Y., Xu Y., Ellisman M., Wong-Staal F. Localization of human immunodeficiency virus Rev in transfected and virus-infected cells. AIDS Res. Hum. Retroviruses. 11:1995;795-804.
19. Marquet R., Baudin F., Gabus C., Darlix J.-L., M. M., Ehresmann C., Ehresmann B. Dimerization of human immunodeficiency virus (type 1) RNA: stimulation by cations and possible mechanism. Nucleic Acids Res. 22:1991;145-151.
20. Mc Bride M. S., Panganiban A. T. The Human Immunodeficiency Virus tye 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:1996;2963-2973.
21. Meyer B. E., Malim M. H. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1994;1538-1547.
22. Paillard J.-C., Berthoux L., Ottmann M., Darlix J.-L., Marquet R., Ehresmann B., Ehresmann C. A dual role of the putative RNA dimerization initiation site of Human Immunodeficiency Virus type 1 in genomic RNA packaging and proviral DNA synthesis. J. Virol. 70:1996;8348-8354.
23. Parolin C., Dorfman T., Palu G., Gottlinger H., Sodroski J. Analysis in Human Immunodeficiency Virus Type 1 vectors ofcis. J. Virol. 68:1994;3888-3895.
24. Poeschla E., Corbeau P., Wong-Staal F. Developing HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA. 93:1996;11395-11399.
25. Poznansky M., Lever A., Bergeron L., Haseltine W., Sodroski J. Gene transfer into human lymphocytes by a defective Human Immunodeficiency Virus type 1 vector. J. Virol. 65:1991;532-536.
26. Shukla R., Kimmet P., Kumar A. Human immunodeficiency virus type 1 Rev-responsive element RNA binds to host cell-specific proteins. J. Virol. 68:1994;2224-2229.
27. Sullenger B. A., Cech T. R. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science. 262:1993;1566-1569.
28. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 63:1990;601-608.
29. Trono D., Feinberg M. B., Baltimore D. HIV-1gag. Cell. 59:1989;113-120.
30. Vaishnav Y., Vaishnav M., Wong-Staal F. Identification and characterization of a nuclear factor that specifically binds to the Rev response element (RRE) of human immunodeficiency virus type 1 (HIV-1). New Biol. 3:1991;142-150.
31. Yu M., Poeschla E., Wong-Staal F. Progress towards gene therapy for HIV infection. Gene Ther. 1:1994;13-26.